Abstract
Object
To compare volumetric modulated arc therapy (VMAT) with 0° and 90° collimator intensity modulated radiation therapy (IMRT) plans for treatment of maxillary sinus carcinomas (MSCs).
Methods
Eighteen MSC were re-planned for VMAT (two full arcs), 0° collimator 9 beams IMRT (zc-IMRT) and 2 beams with 90° collimator and the remaining 7 beams with 0° collimator IMRT (nc-IMRT). The conformity and homogeneity index (CI and HI) of target volume, dose-volume histogram (DVH) of organs at risk (OARs), and monitor units (MUs) were analyzed.
Results
The CI of VMAT with GTV, PTV,1 and PTV2 found significantly more than zc-IMRT and nc-IMRT. The HI of nc-IMRT found significantly smaller than VMAT. In terms of OARs, VMAT significantly reduced the maximum point dose of optic chiasm, the ipsilateral lens, MUs, and the D1% of the ipsilateral lens compared with IMRT. VMAT significantly reduced the maximum point dose of ipsilateral optic nerve, the D1% of optic chiasm, the ipsilateral optic nerve and the mean dose of contralateral eyeball compared with zc-IMRT. For the two IMRT group plans, comparison with zc-IMRT, nc-IMRT could significantly reduce the maximum point dose of ipsilateral lens, the D1% of ipsilateral lens and the MUs.
Conclusions
The VMAT has better CI of target volume and could have better OARs sparing effects for optic chiasm, ipsilateral lens and ipsilateral optic nerve compared with IMRT for MSCs. The VMAT also could use fewer MUs and has lower treatment delivery times. The nc-IMRT could have better ipsilateral lens sparing and use fewer MUs compared with zc-IMRT. Therefore we could protect the ipsilateral lens better through changing the angle of the collimator from 0° to 90° when the IMRT technique is used for the treatment of MSCs.
Similar content being viewed by others
References
Martínez-Rodríguez N, Dorado CB, Brinkmann JCB et al (2018) Dental considerations in diagnosis of maxillary sinus carcinoma: a patient series of 24 cases. J Am Dent Assoc 149:976–982
Dubal PM, Bhojwani A, Patel TD, Zuckerman O, Baredes S, Liu JK, Eloy JA (2016) Squamous cell carcinoma of the maxillary sinus: a population-based analysis. Laryngoscope 126:399–404
Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S (2014) The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation. Eur Arch Oto-Rhino-L 271:2767–2770
Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H (1991) Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 21:193–200
Kim S, Lee IJ, Kim YB, Koom WS, Jeon BC, Lee CG, Kim GE, Keum KC (2009) A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma. Technol Cancer Res Treat 8:257–263
Orlandi E, Giandini T, Iannacone E, de Ponti E, Carrara M, Mongioj V, Stucchi C, Tana S, Bossi P, Licitra L, Fallai C, Pignoli E (2014) Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy. Radiother Oncol 113:260–266
Chera BS, Malyapa R, Louis D, Mendenhall WM, Li Z, Lanza DC, Yeung D, Mendenhall NP (2009) Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol-Canc 32:296–303
Mock U, Georg D, Bogner J, Auberger T, Pötter R (2004) Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 58:147–154
Lomax AJ, Goitein M, Adams J (2003) Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 66:11–18
Lu JY, Zheng J, Zhang WZ et al (2016) Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer. PLoS One 11:e0146604
Gupta S, Laviraj MA, Haresh KP, Sharma DN, Pandey D, Prabhakar R, Rajendran M, Julka PK, Rath GK (2014) A Dosimetric comparison of VMAT and IMRT in Sinonasal cancers. Int J Radiat Oncol Biol Phys 88:493
Jeong Y, Lee S, Kwak J, Cho I, Yoon S, Kim J, Park J, Choi E, Song S, Kim Y, Kim S, Joo J, Ahn S (2014) A Dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiation therapy (IMRT) for nasal cavity and paranasal sinus cancer. Int J Radiat Oncol Biol Phys 90:S865
Narita Y, Kato T, Ono T et al (2018) Effect of anatomical change on dose distribution during radiotherapy for maxillary sinus carcinoma: passive scattering proton therapy versus volumetric-modulated arc therapy. Brit J Radiol 20180273
Huang D, Xia P, Akazawa P, Akazawa C, Quivey JM, Verhey LJ, Kaplan M, Lee N (2003) Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 56:158–168
Lu SH, Cheng JCH, Kuo SH et al (2012) Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 3:324–330
Lee FKH, Yip CWY, Cheung FCH, Leung AKC, Chau RMC, Ngan RKC (2014) Dosimetric difference amongst 3 techniques: TomoTherapy, sliding-window intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma (NPC). Med Dosim 39:44–49
Wang J, Chen Z, Li W, Qian W, Wang X, Hu W (2018) A new strategy for volumetric-modulated arc therapy planning using autoplanning based multicriteria optimization for nasopharyngeal carcinoma. Radiat Oncol 13:94–104
Weiss E, Siebers JV, Keall PJ (2007) An analysis of 6-MV versus 18-MV photon energy plans for intensity-modulated radiation therapy (IMRT) of lung cancer. Radiother Oncol 82:55–62
Bristol IJ, Ahamad A, Garden AS, Morrison WH, Hanna EY, Papadimitrakopoulou VA, Rosenthal DI, Ang KK (2007) Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 68:719–730
Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, Shah JP, Kraus DH, Lee NY (2007) Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience. Int J Radiat Oncol Biol Phys 67:691–702
Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92:3012–3029
Kreppel M, Safi AF, Scheer M, Nickenig HJ, Zöller J, Preuss S, Meyer M, Rothamel D, Dreiseidler T (2016) The importance of early diagnosis in patients with maxillary sinus carcinoma. Eur Arch Oto-Rhino-L 273:2629–2635
Ono T, Tanaka N, Umeno H, Chitose SI, Shin B, Aso T, On K, Hattori C, Etoh H, Kakuma T, Abe T (2017) Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: implications for prognostic factors. J Cranio-Maxillofac Surg 45:2128–2134
Nishio N, Fujimoto Y, Hiramatsu M, Maruo T, Tsuzuki H, Mukoyama N, Shimono M, Sone M, Kawabe Y, Saito K, Fujii M, Nakashima T (2018) Maxillary sinus carcinoma outcomes over 60 years: experience at a single institution. Nagoya J Med Sci 80:91–98
Nishio N, Fujimoto Y, Fujii M, Saito K, Hiramatsu M, Maruo T, Iwami K, Kamei Y, Yagi S, Takahashi M, Hayashi Y, Ando A, Nakashima T (2015) Craniofacial resection for T4 maxillary sinus carcinoma: managing cases with involvement of the Skull Base. Otolaryng Head Neck 153:231–238
Kondo A, Kurose M, Obata K et al (2016) A clinical study of maxillary sinus squamous cell carcinoma. Adv Otorhinolaryngol 77:83–87
Mancosu P, Cozzi L, Fogliata A, Lattuada P, Reggiori G, Cantone MC, Navarria P, Scorsetti M (2010) Collimator angle influence on dose distribution optimization for vertebral metastases using volumetric modulated arc therapy. Med Phys 37:4133–4137
Tas B, Bilge H, Ozturk ST (2016) An investigation of the dose distribution effect related with collimator angle in volumetric arc therapy of prostate cancer. J Med Phys 41:100–105
Acknowledgements
Not applicable.
Availability of data and materials
Please contact author for data requests.
Funding
No funding support is associated with this study.
Author information
Authors and Affiliations
Contributions
YS made the table and drafted the manuscript and planned for treatment cases, GS revised the article, KS performed the analysis and helped to draft the manuscript, FH revised the article, JC delineated the target area and organs at risk. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
ethical approval
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sang, Y., Shan, G., Shao, K. et al. Radiotherapy for maxillary sinus carcinoma: dosimetric comparison of volumetric modulated arc therapy with 0° and 90° collimator intensity modulated radiation therapy. J Radiat Oncol 9, 53–58 (2020). https://doi.org/10.1007/s13566-020-00422-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-020-00422-2